STOCKHOLM, Sweden, July 28, 2005 (PRIMEZONE) -- Biotage interim report January -- June 2005:
-- Sales in the second quarter 2005 amounted to 93.5 MSEK (88.9) and
sales in the period January -- June 2005 to 165.4 MSEK (175.9).
-- The operating result for the second quarter amounted to
-15.5 MSEK (-13.4) and the operating result for the period
January -- June to -37.7 MSEK (-36.1).
-- The net result for the second quarter was positive, amounting to
0.8 MSEK (-11.3).
-- Earnings per share for the second quarter amounted to 0.01
SEK (-0.19) and earnings per share for the period January - June
to --0.20 SEK (-0.56).
-- The business of the American company Argonaut Technologies Inc.
was acquired and is included in Biotage from June 3, 2005. The
purchase price, excluding acquisition costs, was approx. 21.1 MUSD,
157 MSEK, and Biotage has obtained short-term bank financing to
the amount of 140 MSEK. Through the acquisition Biotage gets
additional annual sales of approx. 125 MSEK.
-- In late June Biotage decided to make two new share issues, with a
total of 6.4 million shares. Through these issues the company will
gain new capital amounting to approx. 62 MSEK after deduction
of costs.
Contact:
Jeff Bork, President and CEO
Tel: +46 734-22 16 60
Mats-Olof Wallin, CFO
Tel: +46 705-93 52 73
This information was brought to you by Waymaker.
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=118607&fn=wkr0001.pdf
-0-